Degradation of the GAB1 adaptor by the ubiquitin-proteasome pathway hampers HGF/SF-MET signaling

Biochemical and Biophysical Research Communications

Volumn 411, Issue 4, 2011, Pages 780-785

  Goormachtigh, Gautier ^a   Ji, Zongling ^b   Le Goff, Arnaud ^a   Fafeur, Véronique ^a  

^a UNIV LILLE   (France)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

CBL; Degradation; GAB1; HGF SF; MET; Ubiquitin

Indexed keywords

ADAPTOR PROTEIN; GRB2 ASSOCIATED BINDER 1; MITOGEN ACTIVATED PROTEIN KINASE; PROTEASOME; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DOWN REGULATION; ENZYME REACTIVATION; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UBIQUITINATION;

EID: 80051575123     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.07.024     Document Type: Article

References (29)

1. Holgado-Madruga M., Emlet D.R., Moscatello D.K., Godwin A.K., Wong A.J. A Grb2-associated docking protein in EGF- and insulin-receptor signalling. Nature 1996, 379:560-564.
2. Weidner K.M., Di Cesare S., Sachs M., Brinkmann V., Behrens J., Birchmeier W. Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis. Nature 1996, 384:173-176.
3. Maroun C.R., Naujokas M.A., Holgado-Madruga M., Wong A.J., Park M. The tyrosine phosphatase SHP-2 is required for sustained activation of extracellular signal-regulated kinase and epithelial morphogenesis downstream from the met receptor tyrosine kinase. Mol. Cell. Biol. 2000, 20:8513-8525.
4. Schaeper U., Gehring N.H., Fuchs K.P., Sachs M., Kempkes B., Birchmeier W. Coupling of Gab1 to c-Met, Grb2, and Shp2 mediates biological responses. J. Cell Biol. 2000, 149:1419-1432.
5. Lock L.S., Frigault M.M., Saucier C., Park M. Grb2-independent recruitment of Gab1 requires the C-terminal lobe and structural integrity of the Met receptor kinase domain. J. Biol. Chem. 2003, 278:30083-30090.
6. Nguyen L., Holgado-Madruga M., Maroun C., Fixman E.D., Kamikura D., Fournier T., Charest A., Tremblay M.L., Wong A.J., Park M. Association of the multisubstrate docking protein Gab1 with the hepatocyte growth factor receptor requires a functional Grb2 binding site involving tyrosine 1356. J. Biol. Chem. 1997, 272:20811-20819.
7. Bardelli A., Longati P., Gramaglia D., Stella M.C., Comoglio P.M. Gab1 coupling to the HGF/Met receptor multifunctional docking site requires binding of Grb2 and correlates with the transforming potential. Oncogene 1997, 15:3103-3111.
8. Birchmeier C., Birchmeier W., Gherardi E., Vande Woude G.F. Met, metastasis, motility and more. Nat. Rev. Mol. Cell Biol. 2003, 4:915-925.
9. Itoh M., Yoshida Y., Nishida K., Narimatsu M., Hibi M., Hirano T. Role of Gab1 in heart, placenta, and skin development and growth factor- and cytokine-induced extracellular signal-regulated kinase mitogen-activated protein kinase activation. Mol. Cell. Biol. 2000, 20:3695-3704.
10. Sachs M., Brohmann H., Zechner D., Muller T., Hulsken J., Walther I., Schaeper U., Birchmeier C., Birchmeier W. Essential role of Gab1 for signaling by the c-Met receptor in vivo. J. Cell Biol. 2000, 150:1375-1384.
11. Leroy C., Deheuninck J., Reveneau S., Foveau B., Ji Z., Villenet C., Quief S., Tulasne D., Kerckaert J.P., Fafeur V. HGF/SF regulates expression of apoptotic genes in MCF-10A human mammary epithelial cells. Ann. N. Y. Acad. Sci. 2006, 1090:188-202.
12. Weidner K.M., Sachs M., Riethmacher D., Birchmeier W. Mutation of juxtamembrane tyrosine residue 1001 suppresses loss-of-function mutations of the met receptor in epithelial cells. Proc. Natl. Acad. Sci. USA 1995, 92:2597-2601.
13. Tulasne D., Deheuninck J., Lourenco F.C., Lamballe F., Ji Z., Leroy C., Puchois E., Moumen A., Maina F., Mehlen P., Fafeur V. Proapoptotic function of the MET tyrosine kinase receptor through caspase cleavage. Mol. Cell. Biol. 2004, 24:10328-10339.
14. Deheuninck J., Goormachtigh G., Foveau B., Ji Z., Leroy C., Ancot F., Villeret V., Tulasne D., Fafeur V. Phosphorylation of the MET receptor on juxtamembrane tyrosine residue 1001 inhibits its caspase-dependent cleavage. Cell Signal 2009, 21:1455-1463.
15. Paumelle R., Tulasne D., Kherrouche Z., Plaza S., Leroy C., Reveneau S., Vandenbunder B., Fafeur V. Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway. Oncogene 2002, 21:2309-2319.
16. Ji Z., Degerny C., Vintonenko N., Deheuninck J., Foveau B., Leroy C., Coll J., Tulasne D., Baert J.L., Fafeur V. Regulation of the Ets-1 transcription factor by sumoylation and ubiquitinylation. Oncogene 2007, 26:395-406.
17. Urbe S., Sachse M., Row P.E., Preisinger C., Barr F.A., Strous G., Klumperman J., Clague M.J. The UIM domain of Hrs couples receptor sorting to vesicle formation. J. Cell Sci. 2003, 116:4169-4179.
18. Tulasne D., Paumelle R., Weidner K.M., Vandenbunder B., Fafeur V. The multisubstrate docking site of the MET receptor is dispensable for MET-mediated RAS signaling and cell scattering. Mol. Biol. Cell 1999, 10:551-565.
19. Peschard P., Fournier T.M., Lamorte L., Naujokas M.A., Band H., Langdon W.Y., Park M. Mutation of the c-Cbl TKB domain binding site on the Met receptor tyrosine kinase converts it into a transforming protein. Mol. Cell 2001, 8:995-1004.
20. Taher T.E., Tjin E.P., Beuling E.A., Borst J., Spaargaren M., Pals S.T. C-Cbl is involved in Met signaling in B cells and mediates hepatocyte growth factor-induced receptor ubiquitination. J. Immunol. 2002, 169:3793-3800.
21. Petrelli A., Gilestro G.F., Lanzardo S., Comoglio P.M., Migone N., Giordano S. The endophilin-CIN85-Cbl complex mediates ligand-dependent downregulation of c-Met. Nature 2002, 416:187-190.
22. Thien C.B., Langdon W.Y. C-Cbl and Cbl-b ubiquitin ligases: substrate diversity and the negative regulation of signalling responses. Biochem. J. 2005, 391:153-166.
23. Carter S., Urbe S., Clague M.J. The met receptor degradation pathway: requirement for Lys48-linked polyubiquitin independent of proteasome activity. J. Biol. Chem. 2004, 279:52835-52839.
24. Hammond D.E., Urbe S., Vande Woude G.F., Clague M.J. Down-regulation of MET, the receptor for hepatocyte growth factor. Oncogene 2001, 20:2761-2770.
25. Foveau B., Ancot F., Leroy C., Petrelli A., Reiss K., Vingtdeux V., Giordano S., Fafeur V., Tulasne D. Down-regulation of the met receptor tyrosine kinase by presenilin-dependent regulated intramembrane proteolysis. Mol. Biol. Cell 2009, 20:2495-2507.
26. Peschard P., Ishiyama N., Lin T., Lipkowitz S., Park M. A conserved DpYR motif in the juxtamembrane domain of the Met receptor family forms an atypical c-Cbl/Cbl-b tyrosine kinase binding domain binding site required for suppression of oncogenic activation. J. Biol. Chem. 2004, 279:29565-29571.
27. Dikic I., Giordano S. Negative receptor signalling. Curr. Opin. Cell Biol. 2003, 15:128-135.
28. Abella J.V., Peschard P., Naujokas M.A., Lin T., Saucier C., Urbe S., Park M. Met/Hepatocyte growth factor receptor ubiquitination suppresses transformation and is required for Hrs phosphorylation. Mol. Cell. Biol. 2005, 25:9632-9645.
29. Jeffers M., Taylor G.A., Weidner K.M., Omura S., Vande Woude G.F. Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway. Mol. Cell. Biol. 1997, 17:799-808.